Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early rheumatoid arthritis trial comparing conventional therapy with biologic strategies and remission-guided de-escalation
NL-OMON50439Phase 4Active, not recruiting
- Sponsor
- Ronald van Vollenhove/Karolinska Instituut (clinTRID)
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methotrexate, prednisolone, certolizumab pegol, abatacept and tocilizumab in rheumatoid arthritis (RA), sponsored by Ronald van Vollenhove/Karolinska Instituut (clinTRID). Started Sep 2017; status: active, not recruiting.
02
Drugs
methotrexateprednisolonecertolizumab pegolabatacepttocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON50439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50439.